Cargando…
Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule
IMPORTANCE: The US Food and Drug Administration (FDA) Pregnancy and Lactation Labeling Rule (PLLR), implemented in 2015, includes information on pregnancy, lactation, and women and men with reproductive potential. OBJECTIVES: To identify the drugs that have adhered to the new PLLR format; to shed li...
Autores principales: | Byrne, John J., Saucedo, Alexander M., Spong, Catherine Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489861/ https://www.ncbi.nlm.nih.gov/pubmed/32865574 http://dx.doi.org/10.1001/jamanetworkopen.2020.15094 |
Ejemplares similares
-
Understanding the new FDA pregnancy and lactation labeling rules()
por: Blattner, Collin M., et al.
Publicado: (2016) -
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule()()
por: Abrouk, Michael, et al.
Publicado: (2017) -
Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule()
por: Abrouk, Michael, et al.
Publicado: (2016) -
New changes in pregnancy and lactation labelling: Review of dermatologic drugs
por: Koh, Yun Pei, et al.
Publicado: (2019) -
An overview of upcoming changes in pregnancy and lactation labeling information
por: Mosley, Juan F., et al.
Publicado: (2015)